Dermatology Diagnostic Devices Global Market Report 2024

The dermatology diagnostic devices market size has grown rapidly in recent years. It will grow from $16.12 billion in 2023 to $18.28 billion in 2024 at a compound annual growth rate (CAGR) of 13.4%.the growth observed in the historical period within dermatology diagnostic devices can be primarily attributed to several key factors. These include the increased prevalence of skin disorders and conditions, a heightened awareness regarding skin cancer, notable advancements in dermatological research facilitating improved diagnostic tools, the expansion of aesthetic dermatology procedures, and a notable shift toward preventive dermatological practices. These elements collectively contributed to the growth and development of dermatology diagnostic devices during that time.

The dermatology diagnostic devices market size is expected to see rapidly grown in the next few years. It will grow to $28.77 billion in 2028 at a compound annual growth rate (CAGR) of 12.0%. Anticipated growth in the forecast period within dermatology diagnostic devices is expected to be driven by several significant factors. These include the rising geriatric population leading to increased dermatological needs, a global surge in dermatological disorders, the integration of telemedicine and remote dermatology services for wider access to care, the adoption of personalized approaches in dermatological treatments, and heightened awareness campaigns and educational initiatives for skin health.

The burgeoning incidence of skin cancer is projected to drive the expansion of the dermatology diagnostic devices market. Skin cancer, arising from abnormal skin cell growth due to factors like UV radiation, encompasses various types mandating timely diagnosis and treatment. Dermatology diagnostic devices facilitate more effective diagnosis, prompting increased investments in the sector. For instance, the American Academy of Dermatology Association estimated around 197,000 new melanoma cases in April 2022, emphasizing the market impetus from the rising skin cancer prevalence.

The aging demographic presents a significant catalyst for the growth of the dermatology diagnostic devices market. An aging populace, characterized by an increased elderly proportion, correlates with higher occurrences of skin-related issues such as wrinkles, dryness, and skin cancer susceptibility. As the World Health Organization projects a substantial rise in the elderly population globally by 2030 and beyond, there's a parallel surge in demand for dermatology diagnostic devices to address age-related skin conditions. Leading companies in the dermatology diagnostic devices market are focusing on pioneering technology, like Whole-body 3D imaging, to stimulate market revenues. This advanced imaging technique captures detailed 3D images of the entire body, aiding diagnosis and treatment planning across medical disciplines. An instance is Hoag Hospital's launch of VECTRA WB360 in June 2023, a breakthrough technology revolutionizing early skin cancer detection through comprehensive, rapid, and AI-powered full-body imaging.

Key players in the dermatology diagnostic devices market prioritize innovation, exemplified by products like Derm Assist. Utilizing AI, Derm Assist analyzes user-captured images of skin concerns, offering potential diagnoses and information sourced from the web. Google's introduction of Derm Assist in May 2021 exemplifies this innovation, emphasizing its inclusivity across diverse skin tones and its role in empowering users to make informed decisions about consulting medical professionals.

In December 2021, Canfield Scientific Inc., a leading provider of imaging systems based in the US, successfully acquired Medici Medical S.r.l., an Italian-based manufacturer specializing in dermatology diagnostic devices, for an undisclosed sum. This strategic acquisition aimed to augment Canfield Scientific Inc.'s operational capacities significantly. Moreover, Canfield launched a specialized scientific and educational initiative, named Dreamoscopy, leveraging its newly established cutting-edge facility in Spilamberto (Modena), Italy. Dreamoscopy was designed to offer advanced learning opportunities in medical imaging, focusing on innovative practices and techniques.

Major companies operating in the dermatology diagnostic devices market report are Siemens Healthcare Private Limited, Koninklijke Philips N.V., GE Healthcare Technologies Inc., Valeant Pharmaceuticals International Inc (Bausch Health), Illumina Inc., Galderma laboratories LP, Canon Medical Systems Corporation, Bruker Corporation, Carl Zeiss Meditec AG, Agfa-Gevaert Group, Leica Microsystems GmbH, Welch Allyn Inc., Alma Lasers Ltd., Candela Corp., Solta Medical Inc., MELA Sciences Inc. (STRATA Skin Sciences Inc), Fotofinder Systems GMBH, Aerolase Corp, Photomedex Inc., Canfield Scientific Inc., DermLite LLC, HEINE Optotechnik GmbH & Co. KG., Toshiba Medical Systems Corporation, AMD Global Telemedicine Inc., Spindletop Capital Management LLC.

North America was the largest region in the dermatology diagnostic devices market in 2023. The regions covered in the dermatology diagnostic devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa The countries covered in the dermatology diagnostic devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The main types of dermatology diagnostic devices include dermatoscopes, imaging equipment, microscopes and trichoscopes, biopsy devices, and others, which are used for various applications, such as Dermatitis, Psoriasis, skin cancer, Lesion, Cellulitis, and others, by several end-users, such as dermatology centers, hospitals, and others.

The dermatology diagnostic devices market research report is one of a series of new reports provides dermatology diagnostic devices market statistics, including dermatology diagnostic devices industry global market size, regional shares, competitors with a dermatology diagnostic devices market share, detailed dermatology diagnostic devices market segments, market trends and opportunities, and any further data you may need to thrive in the dermatology diagnostic devices industry. This dermatology diagnostic devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The dermatology diagnostic devices market consists of sales of skin cameras, skin biopsy tools, reflectance confocal microscopes, and skin analyzers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.